Before describing the clinical features it is necessary to define the disorder and the meaning of the term 'obstructive cardiomyopathy'. Sir Russell Brock (1957) first described the condition in this country when, operating for aortic valve stenosis, he found a normal aortic valve and deep to it a mass of hypertrophied left ventricular muscle which was obstructing outflow from the left ventricle. He described the condition as 'functional obstruction of the left ventricle'. Teare (1958) subsequently reported several patients whose hearts at necropsy showed massive hypertrophy, mainly of the ventricular septum, and called the condition 'asymmetrical hypertrophy'. The disorder has received many names from workers in the United States, all of which emphasize the obstruction to left ventricular outflow, simulating aortic stenosis. Titles such as 'pseudo aortic stenosis' (Bercu et al. 1958) , 'familial muscular sub-aortic stenosis' (Brent et al. 1960) and 'hypertrophic sub-aortic stenosis' (Brockenbrough et al. 1961 ) have been used. In 1960, my colleagues at the Postgraduate School and I ) used the term 'obstructive cardiomyopathy', for we believed the condition to be a generalized disorder of heart muscle which produced a number of effects on cardiac function other than obstruction to the outflow of the left ventricle.
The disorder produces hmmodynamic disturbances by a combination of ventricular hypertrophy and disordered contractile function which affects outflow and inflow of both ventricles. There is a striking family history (Hollman et al. Obstructive Cardiomyopathy [Abridged] usually mimic aortic stenosis, and consist of an ejection systolic murmur, often with a thrill, maximal at the left sternal edge. The signs differ from those of aortic valvar, or discrete subvalvar, stenosis in that the pulse is strikingly jerky in character, the systolic murmur begins in midsystole, and an aortic diastolic murmur has not been reported. The systolic murmur is often conducted to the apex and axilla, suggesting mitral insufficiency. Atrial fibrillation is rare. The cardiac impulse usually reflects hypertrophy of the left ventricle, and is often bifid in type due either to a double ventricular thrust, or to a palpable atrial contraction. Signs of inflow tract obstruction to the right side of the heart are frequent and consist of an augmented presystolic 'a' wave in the jugular venous pulse, and a tricuspid diastolic murmur.
HEemodynamic studies have revealed a variable systolic gradient between the aorta and the deeper regions of the outflow tract of the left ventricle, with elevation of the left ventricular systolic pressure, and often of the end-diastolic pressure. Brockenbrough et al. (1961) have emphasized the functional nature of the gradient by showing that it increases in the beat following an ectopic contraction.
Similar outflow gradients occur between the body of the right ventricle and the pulmonary artery and infundibulum, and the right ventricular end-diastolic pressure is often elevated.
In some patients marked hypertrophy is present without obstructive features, the enddiastolic pressure in the ventricles and the mean atrial pressures being raised, indicating resistance to filling of the ventricles by the reduced compliance of the massive ventricular muscle (Braunwald et al. 1960 , Wigle et al. 1962 In about 30% of our 30 patients mitral incompetence, which occurs late in systole, is present, and is probably closely linked to the abnormal contraction of the left ventricle and the outflow gradients.
The functional component has been emphasized by Braunwald & Ebert (1962) and others, who have shown that isoprenaline, an inotropic catechol amine, will produce or exaggerate the gradient, and reduce the effective outflow orifice of the left ventricle. They have also shown that digitalis has the same action, and thus this drug appears to be contraindicated in these patients. We have confirmed these studies, and shown that a similar effect can be produced on the right side of the heart. Furthermore, my colleague Dr P Shah has shown that the inotropic blocking agent pronethalol will prevent the gradient produced by isoprenaline, and sometimes reduce a gradient already present. This drug produces a bradycardia, and the gradient and the systolic murmur can be also reduced by phenylephrine, which has no direct cardiac action, but causes pronounced peripheral vasoconstriction and marked bradycardia. The cardiac output is usually increased in our experience, and this, together with the elevated left ventricular systolic pressures, suggests increased left ventricular work . We believe that tachycardia may be injurious in diminishing ventricular filling time and augmenting inflow and outflow obstruction, the latter increasing as the ventricle contracts more powerfully and in an incoordinate fashion. It is suggested that ventricular hypertrophy may result from, or be increased by, the unusual type of contraction.
The symptoms and physical signs may be explained on the basis of the hemodynamic anomalies in the following ways. The jerky pulse reflects initial unobstructed contraction of the left ventricle, the obstruction occurring in midsystole, and accounting for the timing of the systolic murmur and the double ventricular impulse. The atrial sound reflects atrial enlargement and hypertension due to resistance to ventricular filling. The signs of obstruction to right ventricular inflow are due to the resistance to filling of the right ventricle, and the outflow obstruction to the massive septum bulging into the cavity of the right ventricle. The electrocardiogram reflects the massive hypertrophy by tall R waves and deep T wave inversion in left prxcordial leads, and atrial enlargement. Angina and syncope are due to reduced coronary and cerebral blood flow respectively due to obstruction to left ventricular outflow, while dyspncea results from a high left atrial pressure due to a rigid left ventricle rather than to left ventricular failure.
It has been postulated ) that there may be an excessive or abnormal action of endogenous inotropic catechol amines which initiates or augments an abnormal ventricular contraction, but at this stage this suggestion can be no more than hypothesis.
Our views on the clinical features of the disease and the hxemodynamic and pharmacological abnormalities, together with a review of the literature, are described in full by Cohen et al. (1964) , by and by .
